Esperion Therapeutics, Inc. (ESPR)
3.43
+0.03
(+0.88%)
USD |
NASDAQ |
Feb 13, 16:00
3.435
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Profit Margin (Quarterly) : -35.89% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -301.3% |
| Rigel Pharmaceuticals, Inc. | 40.17% |
| AnaptysBio, Inc. | 19.80% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -31.23% |
| Return on Invested Capital | -60.55% |
| Gross Profit Margin (Quarterly) | 52.71% |
| Operating Margin (Quarterly) | -11.41% |
| Return on Net Operating Assets | -49.76% |